Amphastar Pharmaceuticalsincis A Biopharmaceutical Company Based In Rancho Cucamongacaliforniafounded In 1993 By Drjack Yongfeng Zhang And Drmary Hwamei Jenthe Company Specializes In Complex Generic And Proprietary Injectableinhalationand Intranasal Productsamphastar Also Manufactures Insulin Active Pharmaceutical Ingredientsapisand Operates Cgmp Compliant Facilities The Company Offers A Range Of Productsincluding The Fda Approved Glucagon For Injection Emergency Kitenoxaparin Sodium Injectionand Naloxone Hydrochloride Injectionits Inhalation Products Include Primatene Mistan Otc Epinephrine Inhalerand Glucagon Nasal Powderamphastar Serves Hospitalsurgent Care Clinicsand Long Term Care Facilitiesdistributing Its Products Through Group Purchasing Organizations And Drug Wholesalersthe Company Reported Total Revenues Of $644 7 Million In 2024Driven By Its Focus On Biosimilars And Complex Generics
